Clinical Trials for Advanz Pharma

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Advanz Pharma

Clinical Trials (1)

NCT05117398
Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus
PHASE3Recruiting
406 participants
Started: Jun 23, 2023 · Completed: Sep 23, 2026
2 conditions5 sponsors2 locations